VRDN ($VRDN) Insider Trading & Smart Money Activity
$VRDN has 10 analyst ratings on file.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 10
VRDN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All VRDN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Wedbush | Reiterates to buy | PT $43 | +11.4% | +8.3% | Read | |||||
| Analyst | Wedbush | Reiterates to buy | PT $43 | +11.4% | +8.3% | Read | |||||
| Analyst | Truist Securities | Reiterates to buy | PT $38 | +11.4% | +8.3% | Read | |||||
| Analyst | Truist Securities | Reiterates to buy | PT $38 | +11.4% | +8.3% | Read | |||||
| Analyst | RBC Capital | Reiterates to buy | PT $35 | +11.4% | +8.3% | Read | |||||
| Analyst | RBC Capital | Reiterates to buy | PT $35 | +11.4% | +8.3% | Read | |||||
| Analyst | Needham | Reiterates to buy | PT $34 | +11.4% | +8.3% | Read | |||||
| Analyst | Needham | Reiterates to buy | PT $34 | +11.4% | +8.3% | Read | |||||
| Analyst | Wells Fargo | Raises to buy | PT $31 | +1.1% | +5.8% | Read | |||||
| Analyst | Wells Fargo | Raises to buy | PT $31 | +1.1% | +5.8% | Read |
1W / 1M / 6M = how VRDN moved from the trade or filing date.
Analyst ratings on VRDN
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Wedbush | Reiterates | buy | $43 | +11.4% | +8.3% | Read | ||
| Wedbush | Reiterates | buy | $43 | +11.4% | +8.3% | Read | ||
| Truist Securities | Reiterates | buy | $38 | +11.4% | +8.3% | Read | ||
| Truist Securities | Reiterates | buy | $38 | +11.4% | +8.3% | Read | ||
| RBC Capital | Reiterates | buy | $35 | +11.4% | +8.3% | Read | ||
| RBC Capital | Reiterates | buy | $35 | +11.4% | +8.3% | Read | ||
| Needham | Reiterates | buy | $34 | +11.4% | +8.3% | Read | ||
| Needham | Reiterates | buy | $34 | +11.4% | +8.3% | Read | ||
| Wells Fargo | Raises | buy | $31 | +1.1% | +5.8% | Read | ||
| Wells Fargo | Raises | buy | $31 | +1.1% | +5.8% | Read |
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.